Home > News & Opinion > Q&A

Q&A

Q&A with Luca Santarelli: Targeting neuronal connections

12 June 2012

Comments ( 1 )

Luca Santarelli, head of neuroscience at Roche, explains why he is optimistic that pharmaceutical companies can overcome the obstacles in autism drug development.
Q&A with Eric Fombonne: Are autism's rising rates real?

15 May 2012

Comments ( 4 )

Child psychiatrist and epidemiologist Eric Fombonne digs through the latest report on the prevalence of autism, suggesting reasons for the apparent increase in the disorder’s rates.

New RFAs

SFARI has two new targeted RFAs, one on circuit dynamics and one on Simons VIP biospecimens.

Connectivity

This special report examines the theory that neural connectivity is altered in autism, exploring the latest findings and debates in the field.